Sci. Signal., 21 July 2009
Selective InhibitionInterferon- (IFN-) activates the Janus kinase–signal transducer and activator of transcription (JAK-STAT) pathway to stimulate the production of the proinflammatory mediators that are required for an appropriate immune response. Defects in a required negative regulatory mechanism mediated by suppressor of cytokine signaling (SOCS) proteins are implicated in chronic inflammatory conditions. DiGiandomenico et al. engineered a cell-penetrating form of SOCS1 (CP-SOCS1) expressed in a human cell line that specifically targeted STAT1 to block IFN-–induced production of proinflammatory cytokines and chemokines by macrophages. The application of cell-penetrating proteins produced in human cells has advantages both for research and for potential clinical applications over recombinant proteins purified from bacteria. In addition, CP-SOCS1 may provide a therapeutic strategy against inflammatory diseases.
Citation: A. DiGiandomenico, L. S. Wylezinski, J. Hawiger, Intracellular Delivery of a Cell-Penetrating SOCS1 that Targets IFN- Signaling. Sci. Signal. 2, ra37 (2009).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882